Clinical characteristics of participants diagnosed with cardiovascular disease
| Diagnosis | Sex | Age, mean (range) | Symptoms, n (%) | High FRS, n (%) | Abnormal EST, n (%) | METs achieved on EST, mean (range) |
| Mild CAD | 26 M, 3 F | 60 (38–74) | 9 (31.0) | 9 (31.0) | 18 (62.1) | 14.6 (10.7–24.1) |
| Moderate CAD | 23 M, 1 F | 61 (39–74) | 7 (29.2) | 12 (50.0) | 14 (58.3) | 14.0 (10.0–19.0) |
| Significant CAD | 9 M, 1 F | 63 (50–76) | 1 (10.0)* | 5 (50.0) | 8 (80.0) | 13.4 (7.0–18.7) |
| BAV | 3 M | 46 (39–57) | 1 (33.3) | 1 (33.3) | 1 (33.3) | 16.7 (10.7–20.7) |
| MVP | 6 M, 5 F | 56 (42–68) | 4 (36.4) | 0 (0.0) | 4 (36.4) | 15.2 (10.9–18.6) |
| RHD | 1 F | 63 | 0 (0.0) | 0 (0.0 | 1 (100.0) | 14.1 |
| Arrhythmia (AF, second-degree type II AV block) | 7 M | 64 (56–73) | 3 (42.9) | 3 (42.9) | 7 (100.0) | 14.1 (9.8–18.6) |
| PVC burden | 7 M | 59 (50–66) | 1 (14.3) | 1 (14.3) | 4 (57.2) | 14.6 (9.6–19.3) |
| Probable HCM† | 1 M, 1 F | 40, 60 | 0 (0.00 | 0 (0.0) | 0 (0.0) | 17.2 (15–19.3) |
| Coronary artery anomaly | 2 M | 61, 62 | 0 (0.0) | 1 (50.0) | 2 (100.0) | 12.2 (10.4–14) |
| Inheritable heart disease | 3 M, 1 F | 56 (40–62) | 0 (0.0) | 1 (25.0) | 2 (50.0) | 14.7 (10.4–19.3) |
| Dilated aorta | 14 M, 2 F | 61 (42–74) | 7 (43.4) | 4 (25.0) | 4 (25.0) | 15.0 (10.1–18.6) |
19 participants had multiple diagnoses; therefore, some participants are represented twice.
*Symptom reported was palpitations.
†Both patients declined further testing.
AF, atrial fibrillation; AV, atrioventricular; CAD, coronary artery disease; BAV, bicuspid aortic valve; EST, exercise stress test; F, female; FRS, Framingham Risk Score; HCM, hypertrophic cardiomyopathy; M, male; METs, metabolic equivalent task; MVP, mitral valve prolapse; RHD, rheumatic heart disease; PVC, premature ventricular contraction.